Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R T Silver

Showing results (111-120 of 139) with videos related to

Pageof 14
Sort By:
Medical and Pediatric Oncology|January 1, 1979
Combination chemotherapy for non-Hodgkin lymphomas: a ten year follow-up studyD M Hayes, T F Pajak, V Rege, et al.
World Journal of Surgery|October 1, 1985
A randomized trial of CMF versus CMFVP as adjuvant chemotherapy in women with node-positive stage II breast cancer: a CALGB StudyW C Wood, R B Weiss, D C Tormey, et al.
Leukemia & Lymphoma|December 17, 2002
Efficacy and safety of gemtuzumab ozogamicin in patients with poor-prognosis acute myeloid leukemiaG J Roboz, M A Knovich, R L Bayer, et al.
Blood|September 9, 1999
An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of HematologyR T Silver, S H Woolf, R Hehlmann, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Clinical pharmacology of cytarabine in patients with acute myeloid leukemia: a cancer and leukemia group B studyR A Fleming, R L Capizzi, G L Rosner, et al.
Medical and Pediatric Oncology|January 1, 1979
A comparative trial of daunorubicin, cytosine arabinoside, and thioguanine, and a combination of the three agents for the treatment of acute myelocytic leukemiaP H Wiernik, O J Glidewell, H C Hoagland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Value of molecular monitoring during the treatment of chronic myeloid leukemia: a Cancer and Leukemia Group B studyW Stock, C A Westbrook, B Peterson, et al.
Medical and Pediatric Oncology|January 1, 1975
The use of low-dose prednisone and melphalan in the treatment of poor-risk patients with multiple myelomaJ Cuttner, L R Wasserman, G Martz, et al.
Cancer Chemotherapy Reports|August 1, 1972
Intermittent therapy with 6-mercaptopurine (NSC-755) and methotrexate (NSC-740) given intravenously to adults with acute leukemiaR R Ellison, B Hoogstraten, J F Holland, et al.
Cancer|November 1, 1982
Comparison of oral melphalan, CCNU, and BCNU with and without vincristine and prednisone in the treatment of multiple myeloma. Cancer and Leukemia Group B experienceG G Cornwell, T F Pajak, S Kochwa, et al.
Pageof 14

Showing results (111-120 of 139) with videos related to

Sort By:
Pageof 14
Medical and Pediatric Oncology|January 1, 1979
Combination chemotherapy for non-Hodgkin lymphomas: a ten year follow-up studyD M Hayes, T F Pajak, V Rege, et al.
World Journal of Surgery|October 1, 1985
A randomized trial of CMF versus CMFVP as adjuvant chemotherapy in women with node-positive stage II breast cancer: a CALGB StudyW C Wood, R B Weiss, D C Tormey, et al.
Leukemia & Lymphoma|December 17, 2002
Efficacy and safety of gemtuzumab ozogamicin in patients with poor-prognosis acute myeloid leukemiaG J Roboz, M A Knovich, R L Bayer, et al.
Blood|September 9, 1999
An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of HematologyR T Silver, S H Woolf, R Hehlmann, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Clinical pharmacology of cytarabine in patients with acute myeloid leukemia: a cancer and leukemia group B studyR A Fleming, R L Capizzi, G L Rosner, et al.
Medical and Pediatric Oncology|January 1, 1979
A comparative trial of daunorubicin, cytosine arabinoside, and thioguanine, and a combination of the three agents for the treatment of acute myelocytic leukemiaP H Wiernik, O J Glidewell, H C Hoagland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Value of molecular monitoring during the treatment of chronic myeloid leukemia: a Cancer and Leukemia Group B studyW Stock, C A Westbrook, B Peterson, et al.
Medical and Pediatric Oncology|January 1, 1975
The use of low-dose prednisone and melphalan in the treatment of poor-risk patients with multiple myelomaJ Cuttner, L R Wasserman, G Martz, et al.
Cancer Chemotherapy Reports|August 1, 1972
Intermittent therapy with 6-mercaptopurine (NSC-755) and methotrexate (NSC-740) given intravenously to adults with acute leukemiaR R Ellison, B Hoogstraten, J F Holland, et al.
Cancer|November 1, 1982
Comparison of oral melphalan, CCNU, and BCNU with and without vincristine and prednisone in the treatment of multiple myeloma. Cancer and Leukemia Group B experienceG G Cornwell, T F Pajak, S Kochwa, et al.
Pageof 14